tiprankstipranks
Advertisement
Advertisement

CYTK Stock Latest News

Insider Shake-Up at TransDigm, Cytokinetics, ASE, Alexandria, Itau
Weekend UpdatesInsider Shake-Up at TransDigm, Cytokinetics, ASE, Alexandria, Itau
2d ago
ARE
ASX
Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up
PremiumWeekend Updates
Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up
9d ago
ASX
CLNN
Cytokinetics put volume heavy and directionally bearish
PremiumThe Fly
Cytokinetics put volume heavy and directionally bearish
12d ago
CYTK
Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone
PremiumWeekend Updates
Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone
16d ago
ASX
BSM
Cytokinetics initiated with an Overweight at Wells Fargo
PremiumThe Fly
Cytokinetics initiated with an Overweight at Wells Fargo
17d ago
CYTK
Cytokinetics management to meet with Citizens
PremiumThe FlyCytokinetics management to meet with Citizens
25d ago
CYTK
Cytokinetics price target raised to $95 from $87 at Barclays
Premium
The Fly
Cytokinetics price target raised to $95 from $87 at Barclays
25d ago
CYTK
MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
Premium
Ratings
MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
28d ago
CYTK
Cytokinetics price target raised to $100 from $84 at Mizuho
PremiumThe Fly
Cytokinetics price target raised to $100 from $84 at Mizuho
1M ago
CYTK
JPMorgan ups Cytokinetics target, adds to Analyst Focus List
PremiumThe Fly
JPMorgan ups Cytokinetics target, adds to Analyst Focus List
1M ago
CYTK
Cytokinetics announces four presentations in obstructive HCM at ACC Expo
PremiumThe Fly
Cytokinetics announces four presentations in obstructive HCM at ACC Expo
1M ago
CYTK
Cytokinetics price target raised to $69 from $61 at UBS
PremiumThe Fly
Cytokinetics price target raised to $69 from $61 at UBS
2M ago
CYTK
Cytokinetics Earnings Call Marks High-Stakes Launch Phase
PremiumCompany AnnouncementsCytokinetics Earnings Call Marks High-Stakes Launch Phase
2M ago
CYTK
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
Premium
Company Announcements
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
2M ago
CYTK
Cytokinetics management to meet with B. Riley
Premium
The Fly
Cytokinetics management to meet with B. Riley
2M ago
CYTK
Cytokinetics price target raised to $67 from $66 at BofA
PremiumThe Fly
Cytokinetics price target raised to $67 from $66 at BofA
2M ago
CYTK
Cytokinetics price target raised to $98 from $95 at Stifel
PremiumThe Fly
Cytokinetics price target raised to $98 from $95 at Stifel
2M ago
CYTK
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
PremiumRatings
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
2M ago
CYTK
Cytokinetics price target raised to $96 from $88 at Citizens
PremiumThe Fly
Cytokinetics price target raised to $96 from $88 at Citizens
2M ago
CYTK
Cytokinetics (CYTK) Q4 Earnings Cheat Sheet
PremiumPre-EarningsCytokinetics (CYTK) Q4 Earnings Cheat Sheet
2M ago
CYTK
Cytokinetics price target raised to $101 from $95 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $101 from $95 at RBC Capital
2M ago
CYTK
Cytokinetics transferred with Overweight at Barclays
Premium
The Fly
Cytokinetics transferred with Overweight at Barclays
2M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >